Steady advisory demand and an expanded $600 million Thrive efficiency program support 8% earnings growth. However, softening property and reinsurance rates alongside lower fiduciary investment yields fairly limit valuation expansion, warranting a Hold rating with a $201 price target.
Key points
- $600 million in target Thrive cost efficiencies supports steady operating margin expansion through 2028.
- 5% underlying growth in core risk broking and consulting offsets soft property and reinsurance renewal rates.
- 17.5 times projected 2027 adjusted earnings of $11.50 per share establishes fair value near $201.00.
The call
At $186.54, the stock prices in sustained 5% underlying organic growth and steady margin expansion above 27%. That reflects durable brokerage client retention and the resolution of legacy Australian Greensill litigation charges.
Quarterly Adjusted Diluted EPS ($)- Reported Adjusted EPS
- Analyst Forecast Adjusted EPS
Source: Company filings and analyst estimates, October 15, 2026.
We forecast 2027 adjusted earnings of $11.50 per share on 5% revenue expansion. Accelerating Thrive cost cuts and strong management consulting offset soft property renewal pricing and fading fiduciary interest income. At 17.5 times forward earnings, the shares fairly match historical brokerage multiples.
Valuation
| Metric | 2024 | 2025 | 2026E | 2027E |
|---|
| Revenue | $24.5B | $27.0B | $28.9B | $30.3B |
| Underlying growth | 4.0% | 4.0% | 5.0% | 5.0% |
| Adjusted operating margin | 26.0% | 26.8% | 27.3% | 27.8% |
| Adjusted diluted EPS | $8.95 | $9.75 | $10.60 | $11.50 |
| Target P/E multiple | , | , | , | 17.5x |
| Price target | , | , | , | $201.00 |
Marsh commands a 17.5 times forward multiple, reflecting defensive cash flows and sticky corporate advisory relationships. That multiple aligns with peer averages across insurance brokers while accounting for slower commercial property rate momentum. The balanced risk-reward profile supports our Hold rating.
Risks
- Property and casualty pricing deteriorates faster than anticipated, which would show up in quarterly Marsh Global Insurance Market Index declines.
- Short-term interest rates drop sharply, visible in fiduciary interest income falling below $90 million per quarter.
- Consulting advisory revenue weakens, traceable in slower organic growth within People and Investments.
What would change my mind
Reinsurance pricing hardening at upcoming renewals combined with faster-than-guided margin expansion from Thrive program execution would turn us constructive.